Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems

Treatment of bladder cancer remains a critical unmet need and requires advanced approaches, particularly the development of local drug delivery systems. The physiology of the urinary bladder causes the main difficulties in the local treatment of bladder cancer: regular voiding prevents the maintenan...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Irina V. Marchenko (Yazar), Daria B. Trushina (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: MDPI AG, 2023-12-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8d179d0c71ad4c328197e3c25de4e61d
042 |a dc 
100 1 0 |a Irina V. Marchenko  |e author 
700 1 0 |a Daria B. Trushina  |e author 
245 0 0 |a Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems 
260 |b MDPI AG,   |c 2023-12-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15122724 
500 |a 1999-4923 
520 |a Treatment of bladder cancer remains a critical unmet need and requires advanced approaches, particularly the development of local drug delivery systems. The physiology of the urinary bladder causes the main difficulties in the local treatment of bladder cancer: regular voiding prevents the maintenance of optimal concentration of the instilled drugs, while poor permeability of the urothelium limits the penetration of the drugs into the bladder wall. Therefore, great research efforts have been spent to overcome these hurdles, thereby improving the efficacy of available therapies. The explosive development of nanotechnology, polymer science, and related fields has contributed to the emergence of a number of nanostructured vehicles (nano- and micro-scale) applicable for intravesical drug delivery. Moreover, the engineering approach has facilitated the design of several macro-sized depot systems (centimeter scale) capable of remaining in the bladder for weeks and months. In this article, the main rationales and strategies for improved intravesical delivery are reviewed. Here, we focused on analysis of colloidal nano- and micro-sized drug carriers and indwelling macro-scale devices, which were evaluated for applicability in local therapy for bladder cancer in vivo. 
546 |a EN 
690 |a bladder cancer 
690 |a non-muscle-invasive cancer 
690 |a local intravesical drug delivery 
690 |a colloidal drug delivery systems 
690 |a indwelling devices 
690 |a sustained delivery 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 12, p 2724 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/12/2724 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/8d179d0c71ad4c328197e3c25de4e61d  |z Connect to this object online.